Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomised Double-Blind Placebo-Controlled Study of AZD9668 in Bronchiectasis
2008-000753-35Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiectasis comparing AZD9668 with Placebo (2 arms). Primary endpoints: Absolute neutrophil cell count in sputum, Percentage neutrophil cell count in sputum and 1 more. Started Apr 2008; status: completed.
02
Drugs
alvelestat
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2008-000753-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000753-35.